The client is a U.S. based leading biotechnology company specialized in gene therapy. It is known for its treatment for retinal and metabolic diseases. The client approached Freyr for Regulatory support for DLP, IND submissions, and publishing technology. Freyr supported the client by completing the submissions ahead of time and providing support for all the ongoing eCTD managements.
Download the case study to know how Freyr successfully published approximately 10,000 pages of documents within the quick timeline.